providing solutions to challenges of the 21st century
In 2016, Adebayo Alonge founded RxAll, initially developing an AI-powered spectrometer to combat counterfeit medications. Despite early struggles, a pivot during COVID-19 turned RxAll into a comprehensive pharmacy workflow platform, enhancing success and profitability. By addressing pharmacies' operational needs, adoption surged from 5% to 92%, solidifying their market presence.
Trust is a system that can be structured for effectiveness, yet institutions are struggling with public skepticism. Compliance-driven approaches fail to address underlying trust issues. Successful solutions redesign systems for transparency and verification, improving adoption and building credibility. The future favors those who establish robust trust architectures over mere reputational marketing.
The EU AI Act, enforcing significant penalties for noncompliance, seeks to regulate high-risk AI systems, emphasizing moral governance alongside technical compliance. While necessary, this framework lacks moral architecture, risking harm despite adherence to rules. Builders must prioritize community needs to ensure AI systems serve and do not exclude vulnerable populations.
